case-study

Phase 1 Study of OMN54 – Aneustat

Download Registration

First Name*
Last Name*
Company*
State*
Country
Country
Email*
Phone*
Please only hit the submit button once.
CAPTCHA
I AGREE*
- By submitting this form I agree that Frontage may process my data in the manner described in Frontage’s Privacy Policy.

Thank you for registering!

You now have the option of downloading the resource or viewing the web version below.

Discovery ADME›

Discovery Biology›

Discovery PK and Toxicology›

DMPK›

Safety & Toxicology›

Bioanalytical›

Genomics›

Analytical Services›

Formulation Development & CTM Manufacturing›

Clinical Study Experience›

Biometrics›

Central Laboratory Services›

COVID-19›

Phase 1 Study of OMN54 – Aneustat

Download Registration

Related Resources

Phase 1 Clinical Development Program

Strategies and Solutions for Early Phase Formulation Development and CTM Manufacturing

A Competitive Ligand-binding Assay for the Detection of Neutralizing Antibodies Against XTMAB-16

Discovery ADME›

Discovery Biology›

Discovery PK and Toxicology›

DMPK›

Safety & Toxicology›

Bioanalytical›

Genomics›

Analytical Services›

Formulation Development & CTM Manufacturing›

Clinical Study Experience›

Biometrics›

Central Laboratory Services›

COVID-19›

Discovery ADME
›

Discovery Biology
›

Discovery PK and Toxicology
›

DMPK
›

Safety & Toxicology
›

Bioanalytical
›

Genomics
›

Analytical Services
›

Formulation Development & CTM Manufacturing
›

Clinical Study Experience
›

Biometrics
›

Central Laboratory Services
›

COVID-19
›

Discovery ADME
›

Discovery Biology
›

Discovery PK and Toxicology
›

DMPK
›

Safety & Toxicology
›

Bioanalytical
›

Genomics
›

Analytical Services
›

Formulation Development & CTM Manufacturing
›

Clinical Study Experience
›

Biometrics
›

Central Laboratory Services
›

COVID-19
›